Menopause

  • Sleep-related disorders linked to hypertension in postmenopausal women

    New research suggests sleep disorders in postmenopausal women may raise the risk of hypertension — abnormally high blood pressure. Postmenopausal women tend to have poorer blood pressure control than men of the same age, partly due to falling oestrogen. They also report more sleep problems, including short sleep, trouble sleeping or obstructive sleep apnoea (when [...]

  • Self-guided hypnosis significantly reduces menopausal hot flushes, study finds

    Daily self-guided hypnosis cut hot flushes by over 50 per cent in postmenopausal women, a new clinical trial has found. The multicentre randomised clinical trial tested a six-week, self-administered hypnosis programme against a sham control using white noise. It enrolled 250 postmenopausal women with frequent hot flushes — sudden heat surges that can disrupt sleep [...]

  • Herself and Midi unite on Minnesota women’s care

    Herself Health and Midi Health will deliver hybrid care in Minnesota, linking virtual menopause support with in-person primary care across the Twin Cities. The collaboration connects Midi’s virtual services for midlife women, including perimenopause and menopause care, hormone therapy and mental health, with Herself Health’s primary care available online and at five clinics in Minneapolis–St [...]

  • FDA removes warning label from menopause drugs

    The FDA will remove the menopause drug warning from hormone therapies, citing updated evidence on stroke and heart risks. US health officials said Monday they will drop the boxed warning — the strongest safety alert on a drug label — from more than 20 pills, patches and creams with hormones such as oestrogen and progestin, [...]

  • Dame Lesley Regan vows to ‘revamp’ UK’s Women’s Health Strategy – “we’ve let women and girls down”

    The Women’s Health Ambassador for England, Dame Lesley Regan, has promised to overhaul the government’s 10-year strategy, as she revealed the scale and cost of the UK’s gender health gap three years on. Speaking at Women’s Health Week in London earlier this month, Regan revealed that Health Secretary Wes Streeting has tasked her with “revamping” [...]

  • Most midlife women with menopause symptoms don’t seek care, research finds

    More than 80 per cent of women with menopause symptoms do not seek medical help, despite the impact on daily life, according to new research. The study surveyed nearly 5,000 women aged 45 to 60 across four Mayo Clinic primary care sites, finding that more than three-quarters had experienced symptoms affecting work productivity and overall [...]

  • FDA approves new menopause drug to treat hot flashes and night sweats

    The FDA has approved elinzanetant, a new non-hormonal treatment for menopause that reduces hot flushes and night sweats. Clinical trials in the US, Europe and Israel found the drug significantly reduced both the frequency and severity of hot flushes while improving women’s sleep and quality of life. The approval follows successful results from the double-blind [...]

  • Menopause Society receives US$5m for digital training

    The Menopause Society has secured US$5m from the Steven & Alexandra Cohen Foundation to develop digital training for healthcare professionals. The grant will fund the digital-innovation phase of the NextGen Now initiative, which aims to build a digital ecosystem using advanced technologies to improve education on women’s health in midlife. Launched in June, the initiative [...]

  • Spain faces protests over mammogram scandal

    Thousands of people protested in Seville on Sunday after revelations that 2,300 women were not given the results of mammogram tests showing abnormalities that required follow-up care. The demonstrations targeted Andalusia’s regional government after it emerged that women who had mammograms – X-ray scans used to detect breast cancer – at public hospitals in recent [...]

  • Bayer wins US approval for menopause drug

    Bayer has received US approval for its non-hormonal drug to relieve hot flushes linked to menopause. The US Food and Drug Administration (FDA) has approved Lynkuet for treating moderate to severe vasomotor symptoms – also known as hot flushes – associated with menopause. The approval was based on three late-stage studies that showed Lynkuet reduced [...]